Dewi Kartika Turbawaty
Overview
Explore the profile of Dewi Kartika Turbawaty including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
7
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Turbawaty D, Maulida S, Anadhea D, Ritonga M, Andriyoko B, Wisaksana R, et al.
J Clin Microbiol
. 2025 Mar;
:e0148624.
PMID: 40052808
Tuberculosis (TB) remains a global public health problem. The determination of tuberculosis infection (TBI) using interferon-gamma release assay has now been used widely. We aim to evaluate the positivity rates...
2.
Turbawaty D, Komala D, Andriyoko B
J Multidiscip Healthc
. 2025 Jan;
18():71-81.
PMID: 39816439
Purpose: Omicron is a variant with the highest number of mutations among all Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) viruses, making whole genome sequencing (WGS) an essential tool for public...
3.
Turbawaty D, Sudjadi A, Lismayanti L, Rostini T, Logito V
Int J Gen Med
. 2024 Jul;
17:3329-3335.
PMID: 39081671
Introduction: Corona Virus Disease-19 (COVID-19) is a disease caused by Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2). The most reliable and widely accepted method for diagnosing this infection, despite facing various challenges, is the Reverse...
4.
Indrati A, Sumarpo A, Haryanto J, Rosmiati N, Munaya S, Turbawaty D, et al.
Biomed Rep
. 2024 Jul;
21(3):131.
PMID: 39070110
Individuals with human immunodeficiency virus (HIV) infection are susceptible to immune system dysregulation, particularly during co-infection with (MTB). Although there is an association between cytokine profiles and HIV-MTB co-infection, little...
5.
Pramono L, Tjandrawati A, Turbawaty D, Rostini T, Bestari M, Haryono , et al.
Int J Hepatol
. 2024 Jun;
2024:6635625.
PMID: 38882242
Background: Liver biopsy as the gold standard for assessing the degree and diagnosis of fibrosis still has significant drawbacks, which make the emergence of a much less invasive diagnostic marker...
6.
Hartantri Y, Andriyoko B, Debora J, Rachman F, Susandi E, Ferdian F, et al.
IJID Reg
. 2024 Jun;
11:100379.
PMID: 38855022
Objectives: We aimed to compare the clinical severity and outcome among laboratory-confirmed Omicron variant cases admitted between January and December 2022. Methods: This is a cross-sectional study conducted in Hasan...
7.
Heryaman H, Juli C, Nazir A, Syamsunarno M, Yahaya B, Turbawaty D, et al.
Vaccines (Basel)
. 2024 Mar;
12(3).
PMID: 38543861
Patients with Type 2 diabetes mellitus (T2DM) and Chronic Kidney Disease (CKD) face an increased risk of morbidity and mortality after influenza infection. Several studies have shown that the influenza...
8.
Turbawaty D, Surdjaja N, Indrati A, Lismayanti L, Logito V
Clin Pathol
. 2023 Sep;
16:2632010X231198831.
PMID: 37719805
Introduction: Human immunodeficiency virus (HIV) infection is a risk factor for the occurrence of a large of (Mtb) antigen load in the body. The antigens cocktail namely early secretory antigenic...
9.
Turbawaty D, Sugianli A, Soeroto A, Setiabudiawan B, Parwati I
Int J Microbiol
. 2017 Nov;
2017:3259329.
PMID: 29181028
Pulmonary tuberculosis (TB) is a major global health problem and is one of the top 10 causes of death worldwide. Our study aimed to evaluate the performance of urinary (Mtb)...